Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · IEX Real-Time Price · USD
41.97
+0.18 (0.43%)
At close: Mar 28, 2024, 4:00 PM
41.80
-0.17 (-0.41%)
After-hours: Mar 28, 2024, 7:05 PM EDT

Celldex Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Net Income
-141.43-112.33-70.51-59.78-50.88-151.18-93.03-128.53-127.2-118.08
Upgrade
Depreciation & Amortization
3.012.93.073.934.863.85.314.094.013.4
Upgrade
Share-Based Compensation
23.8915.618.953.924.558.0812.3115.3212.776.85
Upgrade
Other Operating Activities
7.24-9.91-2.4211.53-4.9564.07-24.52-3.9211.536.29
Upgrade
Operating Cash Flow
-107.29-103.73-60.91-40.4-46.42-75.24-99.93-113.04-98.89-101.54
Upgrade
Capital Expenditures
-1.82-1.76-1.22-1.5-0.71-0.47-1.79-2.75-4.88-1.93
Upgrade
Acquisitions
00000004.5900
Upgrade
Change in Investments
-103.9691.7-214.93-96.7217.7930.2948.2667.07-45.32-39.08
Upgrade
Investing Cash Flow
-105.7889.94-216.16-98.2217.0829.8246.4768.91-50.19-41.01
Upgrade
Share Issuance / Repurchase
218.464.08272.37171.2316.2629.4451.2914.48193.151.17
Upgrade
Financing Cash Flow
218.464.08272.37171.2316.2629.4451.2914.48193.151.17
Upgrade
Exchange Rate Effect
000000000.02-0.01
Upgrade
Net Cash Flow
5.39-9.71-4.6932.6-13.08-15.98-2.17-29.6544.09-141.38
Upgrade
Free Cash Flow
-109.11-105.49-62.13-41.9-47.13-75.71-101.72-115.79-103.76-103.47
Upgrade
Free Cash Flow Margin
-1585.20%-4475.65%-1335.86%-564.86%-1318.95%-793.73%-798.23%-1706.26%-1893.49%-2885.28%
Upgrade
Free Cash Flow Per Share
-2.25-2.25-1.45-1.41-3.25-7.25-11.87-17.11-16.04-17.36
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).